Tuesday, November 29, 2022
Nov. 29, 2022

Linkedin Pinterest

Premera waives costs for COVID-19 treatment

The Columbian

Premera Blue Cross has announced it is waiving consumer cost shares and deductibles for treatment related to COVID-19 for its fully insured, Medicare and individual market customers through Oct. 1.

According to a company press release, Premera and LifeWise Health Plan of Washington customers won’t have to pay out of pocket for treatment of COVID-19 or health complications associated with COVID-19. That includes inpatient and outpatient hospital admissions, urgent care and emergency room visits, medical transport when needed, and FDA-approved inpatient medications for both in- and out-of-network providers.

Premera will work with self-funded customers who want to implement a similar approach. Customers should check their benefit plans first.

For group and individual customers, this includes any claims received since Jan. 1, related to COVID-19, which will be reprocessed to waive all cost shares and deductibles. For Medicare customers, claims received since Feb. 4, related to COVID-19, will be reprocessed to waive all cost shares and deductibles.

Premera Blue Cross had already waived cost shares for novel coronavirus testing.


Support local journalism

Your tax-deductible donation to The Columbian’s Community Funded Journalism program will contribute to better local reporting on key issues, including homelessness, housing, transportation and the environment. Reporters will focus on narrative, investigative and data-driven storytelling.

Local journalism needs your help. It’s an essential part of a healthy community and a healthy democracy.

Community Funded Journalism logo